Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation

References

• Elwyn G, Laitner S, Coulter A, et al. Implementing shared decision making in the NHS. BMJ 2010;341:c5146
   PubMed Web of Science ®Google Scholar
• Greenes R. Clinical Decision Support: The Road Ahead. Boston, MA: Academic Press, 2011
   Google Scholar
• Stacey D, Legare F, Col NF, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2014;1:CD001431
   PubMed Web of Science ®Google Scholar
• Lee CN, Dominik R, Levin CA, et al. Development of instruments to measure the quality of breast cancer treatment decisions. Health Expect 2010;13:258-72
   PubMed Web of Science ®Google Scholar
• Bensing J. Bridging the gap. The separate worlds of evidence-based medicine and patient-centered medicine. Patient Educ Couns 2000;39:17-25
   PubMed Web of Science ®Google Scholar
• Barry MJ, Edgman-Levitan S. Shared decision making – pinnacle of patient-centered care. N Engl J Med 2012;366:780-1
   PubMed Web of Science ®Google Scholar
• Coulter A, Ellins J. Effectiveness of strategies for informing, educating, and involving patients. BMJ 2007;335:24-7
   PubMed Web of Science ®Google Scholar
• Sheridan SL, Shadle J, Simpson RJ, Pignone MP. The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Serv Res 2006;6:121
   PubMed Web of Science ®Google Scholar
• Hanson L, Carey T, Caprio A, et al. Improving decision making for feeding options in advanced dementia: a randomized, controlled trial. J Am Geriatrics Soc 2011;59:2009-16
   PubMed Web of Science ®Google Scholar
• Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med 2007;167:1076-82
   PubMed Web of Science ®Google Scholar
• Mullan RJ, Montori VM, Shah ND, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med 2009;169:1560-8
   PubMed Web of Science ®Google Scholar
• Hess EP, Knoedler MA, Shah ND, et al. The chest pain choice decision aid: a randomized trial. Circ Cardiovasc Qual Outcomes 2012;5:251-9
   PubMed Web of Science ®Google Scholar
• Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 2010;181:566-77
   PubMed Web of Science ®Google Scholar
• Harrington J, Noble LM, Newman SP. Improving patients' communication with doctors: a systematic review of intervention studies. Patient Educ Counsel 2004;52:7-16
   PubMed Web of Science ®Google Scholar
• Jamison R, Ross M, Hoopman P, et al. Assessment of postoperative pain management: patient satisfaction and perceived helpfulness. Clin J Pain 1997;12:229-36
   Web of Science ®Google Scholar
• Hermoni D, Borkan JM, Pasternak S, et al. Doctor–patient concordance and patient initiative during episodes of low back pain. Br J Gen Pract 2000;50:809-10
   PubMed Web of Science ®Google Scholar
• Montori VM, Shah ND, Pencille LJ, et al. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med 2011;124:549-56
   PubMed Web of Science ®Google Scholar
• Elwyn G, Kreuwel I, Durand MA, et al. How to develop web-based decision support interventions for patients: a process map. Patient Educ Counsel 2011;82:260-5
   PubMed Web of Science ®Google Scholar
• Flynn D, Ford GA, Stobbart L, et al. A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: lessons for tool developers. BMC Health Serv Res 2013;13:225
   PubMed Web of Science ®Google Scholar
• Durand MA, Stiel M, Boivin J, Elwyn G. Where is the theory? Evaluating the theoretical frameworks described in decision support technologies. Patient Educ Counsel 2008;71:125-35
   PubMed Web of Science ®Google Scholar
• Thomson R, Robinson A, Greenaway J, et al. Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Qual Saf Health Care 2002;11:25-31
   PubMed Web of Science ®Google Scholar
• Elwyn G, O'Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One 2009;4:e4705
   PubMed Web of Science ®Google Scholar
• Coulter A, Stilwell D, Kryworuchko J, et al. A systematic development process for patient decision aids. BMC Med Informat Decis Making 2013;13(Suppl 2):S2
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146:857-67
   PubMed Web of Science ®Google Scholar
• DiMarco JP, Flaker G, Waldo AL, et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:650-6
   PubMed Web of Science ®Google Scholar
• Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001;119(1 Suppl):108-21S
   Web of Science ®Google Scholar
• Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011;58:395-401
   PubMed Web of Science ®Google Scholar
• Thomson RG, Eccles MP, Steen IN, et al. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial. Qual Saf Health Care 2007;16:216-23
   PubMed Web of Science ®Google Scholar
• Nicolai R, Saha S, Schechtel M, Hickam D. Radiofrequency Ablation for Atrial Fibrillation: A Guide for Adults. 2009. Available at: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=348&returnpage=. Accessed 1 May 2015
   Google Scholar
• Man-Son-Hing M, Laupacis A, O'Connor AM, et al. Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy. J Gen Intern Med 2000;15:723-30
   PubMed Web of Science ®Google Scholar
• Pai R, Miller J. Atrial Fibrillation: Which Anticoagulant Should I Take to Prevent Stroke? 2013. Available at: https://www.healthwise.net/cochranedecisionaid/Content/StdDocument.aspx?DOCHWID=abl2009. Accessed 1 May 2015
   Google Scholar
• Hess PL, Mirro MJ, Diener HC, et al. Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3–4, 2012. Am Heart J 2014;168:239-47.e1
   PubMed Web of Science ®Google Scholar
• Karcher R, Berman AE, Gross H, et al. Addressing disparities in stroke prevention for atrial fibrillation: educational opportunities. Am J Med Qual 2015. [Epub ahead of print]. pii: 1062860615577971
   PubMedGoogle Scholar
• Ogilvie IM, Newton N, Welner SA, et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010;123:638-45 e4
   PubMed Web of Science ®Google Scholar
• Patel AA, Lennert B, Macomson B, et al. Anticoagulant use for prevention of stroke in a commercial population with atrial fibrillation. Am Health Drug Benefits 2012;5:291-8
   PubMedGoogle Scholar
• Seaburg L, Hess EP, Coylewright M, et al. Shared decision making in atrial fibrillation: where we are and where we should be going. Circulation 2014;129:704-10
   PubMed Web of Science ®Google Scholar
• Pai R, Miller J. Atrial fibrillation: should I take an anticoagulant to prevent stroke? 2013. Available at: https://www.healthwise.net/cochranedecisionaid/Content/StdDocument.aspx?DOCHWID=tx2209. Accessed 1 May 2015
   Google Scholar
• NICE. Atrial fibrillation: medicines to help reduce your risk of a stroke – what are the options? National Institute for Health and Care Excellence (NICE), 2014
   Google Scholar
• Elwyn G, O'Connor A, Stacey D, et al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 2006;333:417
   PubMed Web of Science ®Google Scholar
• Myers R, Daskalakis C, Kunkel E, et al. Mediated decision support in prostate cancer screening: a randomized controlled trial of decision counseling. Patient Educ Counsel 2011;8:240-6
   Web of Science ®Google Scholar
• Krueger RA, Casey MA. Focus groups: a practical guide for applied research, 3rd edn. Thousand Oaks, CA: Sage Publications, 2000
   Google Scholar
• Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70
   PubMed Web of Science ®Google Scholar
• Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72
   PubMed Web of Science ®Google Scholar
• You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e531-75S
   Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010;138:1093-100
   PubMed Web of Science ®Google Scholar
• Apostolakis S, Lane DA, Guo Y, et al. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol 2012;60:861-7
   PubMed Web of Science ®Google Scholar
• Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151:713-19
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre. Atrial Fibrillation: The Management of Atrial Fibrillation. London: National Clinical Guideline Centre, 2014
   Google Scholar
• Dzeshka MS, Lane DA, Lip GY. Stroke and bleeding risk in atrial fibrillation: navigating the alphabet soup of risk-score acronyms (CHADS2, CHA2DS2-VASc, R2CHADS2, HAS-BLED, ATRIA, and more). Clin Cardiol 2014;37:634-44
   PubMed Web of Science ®Google Scholar
• Roldan V, Marin F, Fernandez H, et al. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a ‘real-world' population with atrial fibrillation receiving anticoagulant therapy. Chest 2013;143:179-84
   PubMed Web of Science ®Google Scholar
• Caldeira D, Costa J, Fernandes RM, et al. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis. J Intervent Card Electrophysiol 2014;40:277-84
   Web of Science ®Google Scholar
• Zimetbaum PJ, Thosani A, Yu HT, et al. Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med 2010;123:446-53
   PubMed Web of Science ®Google Scholar
• Riva N, Smith DE, Lip GY, Lane DA. Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. Age Ageing 2011;40:653-5
   PubMed Web of Science ®Google Scholar
• Lane DA, Lip GY. Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation 2012;126:860-5
   PubMed Web of Science ®Google Scholar
• Chewning B, Bylund CL, Shah B, et al. Patient preferences for shared decisions: a systematic review. Patient Educ Counsel 2012;86:9-18
   PubMed Web of Science ®Google Scholar
• Ryan J, Sysko J. The contingency of patient preferences for involvement in health decision making. Health Care Manag Rev 2007;32:30-6
   PubMed Web of Science ®Google Scholar
• Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med 2012;27:1361-7
   PubMed Web of Science ®Google Scholar
• Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol 2000;55:68-78
   PubMed Web of Science ®Google Scholar
• Entwistle VA, Carter SM, Cribb A, McCaffery K. Supporting patient autonomy: the importance of clinician-patient relationships. J Gen Intern Med 2010;25:741-5
   PubMed Web of Science ®Google Scholar
• Sardar P, Chatterjee S, Wu WC, et al. New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons. PLoS One 2013;8:e77694
   PubMed Web of Science ®Google Scholar
• Coleman CM, Khalaf S, Mould S, et al. Novel oral anticoagulants for DC cardioversion procedures: utilization and clinical outcomes compared with warfarin. Pacing Clin Electrophysiol 2015. [Epub ahead of print]. doi: 10.1371/journal.pone.0100478
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Lip GY, Reboldi G. Edoxaban in the evolving scenario of non vitamin K antagonist oral anticoagulants imputed placebo analysis and multiple treatment comparisons. PLoS One 2014;9:e100478
   PubMed Web of Science ®Google Scholar
• Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study. Thromb Haemostasis 2012;107:1172-9
   PubMed Web of Science ®Google Scholar